The company’s pipeline products candidate includes BA3011 (mecbotamab vedotin) targets undifferentiated pleomorphic sarcoma, non-small cell lung cancer; BA3021 (ozuriftamab vedotin) for melanoma, ...

The company’s pipeline products candidate includes BA3011 (mecbotamab vedotin) targets undifferentiated pleomorphic sarcoma, non-small cell lung cancer; BA3021 (ozuriftamab vedotin) for melanoma, ...

Presentation Details: Title:Phase 2 trial of ozuriftamab vedotin (BA3021), a SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology ...

The team believes that the structure was in use until the 8th century BCE, the middle of the period when the Kings of Judah ruled. A scarab seal from the 8th century BCE uncovered during the ...

BioAtla, Inc. (NASDAQ:BCAB – Get Free Report) shares traded down 6.1% during trading on Monday .The stock traded as low as $0.48 and last traded at $0.50. 1,421,670 shares changed hands during ...

This study demonstrates the utility of Nectin-4-targeted positron emission tomography (PET) imaging using [68Ga]AJ647 as a non-invasive tool for real-time assessment of target engagement in enfortumab ...

Earth's inner core may actually have two distinct layers. (alexlmx/Canva Pro) "We found evidence that may indicate a change in the structure of iron, which suggests perhaps two separate cooling events ...

The intention-to-treat population included all randomly assigned patients, and the safety population included patients who received ≥1 dose of the study treatment. BV, brentuximab vedotin; Len, ...

Presentation Details: Title:Phase 2 trial of ozuriftamab vedotin (BA3021), a SAN DIEGO, Aug. 28, 2024 (GLOBE NEWSWIRE) -- BioAtla, Inc. (Nasdaq: BCAB), a global clinical-stage biotechnology company ...